title: Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function.
abstract: BACKGROUND
  Clinical markers to predict adverse outcome have not yet been established for patients with preserved left ventricular (LV) systolic function. The present study was designed to examine whether carboxy-terminal telopeptide of type I collagen (ICTP), a marker of collagen degradation, is useful for determining the prognosis of such patients.
  
  
  RESULTS
  Serum levels of ICTP were measured at admission in 156 consecutive patients hospitalized for chronic heart failure (CHF). Patients were divided into 2 groups based on the LV ejection fraction (LVEF): reduced LV systolic function group (LVEF <50%, n=92) and preserved LV systolic function group (LVEF > or =50%, n=64). In preserved LV systolic function group, cardiac event-free rates were significantly lower in high ICTP group than in low ICTP group (p<0.001). The area under the receiver operating characteristic curve of ICTP in the preserved LV systolic function group was markedly larger than that in the reduced LV systolic function group. Cox multivariate analysis also revealed that ICTP was an independent predictor of cardiac events in the preserved LV systolic function group.
  
  
  CONCLUSIONS
  Serum ICTP level is highly reliable for risk stratifying CHF patients with preserved LV systolic function.
authors.affiliation: Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Kitahara
authors.forename: Yasuchika
authors.initials: Y
authors.lastname: Takeishi
authors.forename: Takanori
authors.initials: T
authors.lastname: Arimoto
authors.forename: Takeshi
authors.initials: T
authors.lastname: Niizeki
authors.forename: Yo
authors.initials: Y
authors.lastname: Koyama
authors.forename: Toshiki
authors.initials: T
authors.lastname: Sasaki
authors.forename: Satoshi
authors.initials: S
authors.lastname: Suzuki
authors.forename: Naoki
authors.initials: N
authors.lastname: Nozaki
authors.forename: Osamu
authors.initials: O
authors.lastname: Hirono
authors.forename: Joji
authors.initials: J
authors.lastname: Nitobe
authors.forename: Tetsu
authors.initials: T
authors.lastname: Watanabe
authors.forename: Isao
authors.initials: I
authors.lastname: Kubota
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D024042:Collagen Type I / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000097:blood* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood*; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D015996:Survival Rate; D013599:Systole; D016277:Ventricular Function, Left
chemical_list: D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides